Halozyme Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $299.4M | $298.0M | $1.5M | $20.8M |
| FY2022 | $240.1M | $235.3M | $4.8M | $24.4M |
| FY2023 | $388.6M | $373.3M | $15.3M | $36.6M |
| FY2024 | $479.1M | $468.4M | $10.7M | $43.4M |
| FY2025 | $651.6M | $644.6M | $7.0M | $51.6M |